Investigation of the Simplify® Cervical Artificial Disc
Public ClinicalTrials.gov record NCT02667067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Study Protocol for the Investigation Of The Simplify® Cervical Artificial Disc
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is intended to demonstrate that the Simplify® Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat one level between C3 to C7 for cervical degenerative disc disease (DDD) defined as intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain or myelopathy due to a single-level abnormality localized to the level of the disc space in subjects who are unresponsive to conservative management.
Study identification
- NCT ID
- NCT02667067
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2015 (Actual)
- Primary completion
- Mar 23, 2020 (Actual)
- Completion
- Jul 29, 2021 (Actual)
- Last update posted
- Jan 8, 2026
2015 – 2021
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | La Jolla | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Thornton | Colorado | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Carmel | Indiana | — | — |
| Not listed | Paducah | Kentucky | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Egg Harbor | New Jersey | — | — |
| Not listed | Lockport | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Addison | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Tyler | Texas | — | — |
| Not listed | Reston | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02667067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02667067 live on ClinicalTrials.gov.